ElwoodJM. Melanoma and sun exposure. Semin Oncol1996; 23:650–666.
2.
AckermanAB. No one should die of malignant melanoma. J Am Acad Dermatol1985; 12:115–116.
3.
MacKieRMMcHenryPHoleD. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet1993; 341:1618–1620.
4.
MasriGDClarkWHGuerryD. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol1990; 22: 1042–1048.
5.
CareyWPThompsonCJSynnestvedtM. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer1994; 74:3118–3125.
6.
VasenHFABergmanWvan HaeringenA. The familial dysplastic nevus syndrome: Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands. Eur J Cancer Clin Oncol1989; 25:337–341.
7.
Titus-ErnstoffLBarnhillPLErnstoffMS. Usefulness of frequent skin examination for the early detection of second primary cutaneous melanoma. Cancer Detect Prev1989; 13: 317–321.
8.
SchneiderJSMooreDHSagebielRW. Risk factors for melanoma incidence in prospective follow-up. Arch Dermatol1994; 130: 1002–1007.
9.
RigelDSRiversJKKopfAW. Dysplastic nevi: Markers for increased risk for melanoma. Cancer1989; 63:386–389.
10.
BaleSJDracopoliNCTuckerMA. The genetics of human cutaneous malignant melanoma. In: BalchCMMiltonGWSoongS-J, eds. Cutaneous melanoma. 2nd Ed.Philadelphia: JB Lippincott, 1992:93–100.
11.
DugglebyWFStollHPrioreRL. A genetic analysis of melanoma—polygenic inheritance as a threshhold trait. Am J Epidemiol1981; 114:63–72.
WhiteEKirkpatrickCSLeeJAH. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol1994; 139:857–868.
14.
MarrettLDKingWDWalterSDFromL. Use of host factors to identify people at high risk for cutaneous malignant melanoma. Can Med Assoc J1992; 147:445–453.
15.
TuckerMAHalpernAHollyEA. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma. JAMA1997; 277:1439–1444.
16.
MacKieRMHoleD. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ1992; 304:1012–1015.
17.
CristofoliniMBianchiRBoiS. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer1993; 71: 370–374.
18.
MeliaJCooperEJFrostT. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. I. Work-load and referral patterns. Br J Dermatol1995; 132:405–413.
19.
RampenFHBerrettyPJvan HuysteeBE. General practitioners' workload after skin cancer/melanoma screening clinics in The Netherlands. Dermatology1993; 186:258–260.
20.
McDonaldCJ. Status of screening for skin cancer. Cancer1993; 72:1066–1070.
21.
KohHKNortonLAGellerAC. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol1996; 34:971–978.
22.
WeinstockMAGoldsteinMGDubéCE. Basic skin cancer triage for teaching melanoma detection. J Am Acad Dermatol1996; 34:1063–1066.
23.
GirgisAClarkePBurtonRCSanson-FisherRW. Screening for melanoma by primary health care physicians: A cost-effectiveness analysis. J Med Screen1996; 3:47–53.
24.
KohHKGellerACMillerDRLewRA. The early detection of and screening for melanoma: International status. Cancer1995; 75:674–683.
25.
GoldsmithLAKohHKBewerseBA. Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. J Am Acad Dermatol1996; 35:748–756.
26.
MillerDRGellerACWyattSW. Melanoma awareness and self-examination practices: Results of a United States survey. J Am Acad Dermatol1996; 34:962–970.
27.
BaadePDBalandaKPStantonWR. Community perceptions about the important signs of early melanoma. J Am Acad Dermatol1997; 36:33–39.
28.
BorlandRMarksRNoyS. Public knowledge about characteristics of moles and melanomas. Aust J Public Health1992; 16:370–375.
29.
HanrahanPFHerseyPMenziesSW. Examination of the ability of people to identify early changes of melanoma in computer-altered pigmented skin lesions. Arch Dermatol1997; 133: 301–311.
30.
KohHKMillerDRGellerAC. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol1992;26:914–919.
31.
U.S. Preventive Services Task Force.Guide to clinical preventive services. 2nd Ed.Baltimore: Williams & Wilkins, 1996:141–152.
32.
BerwickMBeggCBFineJA. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst1996; 88: 17–23.
33.
BalandaKPLoweJBStantonWRGillespieAM. Enhancing the early detection of melanoma within current guidelines. Aust J Public Health1994; 18:420–423.
34.
GreenAMacLennanRYoulPMartinN. Site distribution of cutaneous melanoma in Queensland. Int J Cancer1993; 53:232–236.
35.
OsterlindAHou-JensenKJensenOM. Incidence of cutaneous malignant melanoma in Denmark 1978–1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer1988; 58:385–391.
36.
HillDWhiteVBorlandRCockburnJ. Cancer-related beliefs and behaviors in Australia. Aust J Public Health1991; 15:14–23.
37.
Anonymous. Harvard Report on Cancer Prevention. Causes of Human Cancer. Ultraviolet Light. Cancer Causes Control1996; 7:S39–S40.
